Mahadevia Ankit 4
4 · Spero Therapeutics, Inc. · Filed Feb 5, 2025
Insider Transaction Report
Form 4
Mahadevia Ankit
Director
Transactions
- Sale
Common Stock
2025-02-05$0.78/sh−13,959$10,888→ 745,126 total - Sale
Common Stock
2025-02-05$0.78/sh−55,260$43,103→ 689,866 total
Footnotes (3)
- [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on February 1, 2022.
- [F2]Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.
- [F3]The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on February 1, 2023.